[Inferon clinicoimmunological efficacy in chronic obstructive pulmonary disease].
To study efficacy of leukocytic interferon--inferon in combined treatment of patients with chronic obstructive pulmonary disease (COPD). The trial included 57 COPD patients (mean age 61.2 +/- 1.04 years). Of them, 29 patients received standard treatment (antibiotics, broncholytics, mucolytics). Inferon was added to standard treatment of 28 patients. Standard treatment alone was not highly effective in COPD patients as the symptoms often persisted and immune status was deficient. Adjuvant inferon activated immunity and raised efficacy of COPD therapy. Inferon enhanced immunity in COPD patients and improved treatment results.